Immunogenicity Summit

2013 Speaker Presentation Downloads


Immunogenicity Assessment Challenges for Nanobody® Programs: Strategies and Case Studies to Overcome Drug and Target InterferenceImmunogenicity Assessment Challenges for Nanobody® Programs: Strategies and Case Studies to Overcome Drug and Target Interference

Lieselot Bontinck, M.Sc., Scientist, Pharmacology, Bioanalytics & Immunogenicity, Ablynx N.V

Click to Download 

 

Evaluation of Processes for Reducing and Monitoring Assay Variability for BioassaysEvaluation of Processes for Reducing and Monitoring Assay Variability for Bioassays

Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefense Division, Emergent BioSolutions

Click to Download  

 

Optimization of Ligand Binding Assay by Design of ExperimentOptimization of Ligand Binding Assay by Design of Experiment

Surendran Rajendran, Ph.D., Senior Research Investigator, BAS-Biologics, Bristol-Myers Squibb

Click to Download 

 

Novel Platform Using LC-MS and Ligand Binding Assays for Characterizing PK and Immunogenicity of ADCsNovel Platform Using LC-MS and Ligand Binding Assays for Characterizing PK and Immunogenicity of ADCs

Melody Sauderborn, Senior Expert Immunogenicity and Bioanalysis, TNO, a Netherlands Applied Research Center

Click to Download  

 

Understanding the Immune Response Against Erythropoiesis Stimulating Agents That Can Lead to Pure Red Cell AplasiaUnderstanding the Immune Response Against Erythropoiesis Stimulating Agents That Can Lead to Pure Red Cell Aplasia

Steven J. Swanson, Ph.D., Executive Director, Medical Sciences (Clinical Immunology), Amgen, Inc.

Click to Download  

 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


2014 Brochure Cover

Download Brochure 

Premier Sponsor : 


 Charles River(1) 



Podcast 

IMN Podcast iconReducing and Monitoring Bioassay Variability 

2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions